| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Cytochrome c release into the cytosol has been implicated as an intermediate event in the initiation of apoptosis after a variety of toxic and other stimuli and injury in several cell types4-9 ; it also serves as a useful model, inasmuch as we found that after microinjection, the early phase of apoptosis usually begins within 30 minutes. This means that the progression of changes in single injected cells can be followed by many important techniques. These include the use of time-lapse phase-contrast video microscopy, digital imaging fluorescence, and confocal microscopy to analyze mitochondrial membrane potential, mitochondrial permeability transition, cytosolic calcium concentration [Ca2+]i, and cell death, as well as phase-contrast and electron microscopy for morphological characterization.
The results clearly defined three principal prelethal stages or phases of apoptosis and characterized the morphology at the light and electron microscope levels. We also showed that ATP is required for the initiation of apoptosis, that the loss of mitochondrial membrane potential and the precipitation of the mitochondrial permeability transition occur immediately before cell death, and that increased [Ca2+]i occurs in the prelethal phase just before cell death. The results also revealed that after apoptotic cell death the necrosis phase is essentially identical to the necrotic phase that is seen after the induction of oncosis, eg, by chemical anoxia or nephrotoxins such as mercuric chloride.
| Materials and Methods |
|---|
|
|
|---|
All media and additives were obtained from Gibco-BRL. The NRK-52E normal kidney cell line (CRL 1571) was obtained from the American Type Culture Collection. This cell line is derived from the proximal tubule epithelium (PTE) of the rat kidney, is nontumorigenic, and retains many morphological and physiological characteristics of PTE in vivo.10,11 Cells were grown in low-glucose Dulbeccos modified Eagles medium (DMEM) with 10% fetal bovine serum and antibiotics (100 U/ml penicillin, 100 µg/ml streptomycin) and maintained at 37°C in 5% CO2, 95% air. Cells were plated onto 0.8 x 1.4 cm segments of letter-identified, grid-embossed glass slides (Cel-Line) and grown to about 40% confluency for microinjection.
Microinjection and Examination of Cells
Before microinjection, a grid slide with cells was transferred to a special culture dish that was constructed by predrilling a hole in the bottom of the dish and gluing a cover glass over the hole with aquarium cement. The dish was placed on the stage of an Olympus IMT-2 inverted microscope equipped with a Narishige microinjection system. The cytoplasm of the cells, which averaged 4 µl in volume, was microinjected with approximately 1 fl of 500 µmol/L (6.2 mg/ml) rat heart cytochrome c (Sigma) containing 5 µg/ml Texas Red dextran (Molecular Probes). For each slide usually four to five grid windows of cells were injected, to achieve a total of 200300 injected cells. The cells were followed by phase-contrast and fluorescence microscopy, using a Texas Red, UV, or rhodamine filter, for up to 24 hours. For time-lapse video microscopy, a video camera was interfaced between the microscope and the tape recorder. Images were recorded at 1/60 of normal time.
Examination and Evaluation of Apoptotic Cells
Apoptotic cells were evaluated by phase-contrast and fluorescence microscopy; the presence of Texas Red fluorescence was used to confirm that the cell had been microinjected. In addition, the DNA-binding fluorphore dye Hoechst 33342 (1 µmol/ml) was used to further evaluate chromatin morphology in living cells. The percentage of Texas Red positive cells that showed morphological features of apoptosis was calculated every 30 minutes for 5 hours in 18 separate experiments. Propidium iodide was used to identify dead cells. In addition, cells were fixed for 10 minutes in 2% phosphate-buffered paraformaldehyde, followed by 20 minutes in absolute methanol, and then mounted with Vectashield mounting medium (Vector Labs) containing 0.5 µg/ml diamidino phenylindole (DAPI) for DNA staining. Microinjected cells fixed in buffered paraformaldehyde were stained with an ApopTag plus fluorescein assay kit from Intergen Co. (Purchase, NY) (formerly a product of Oncor, Gaithersburg, MD) to detect DNA fragmentation in morphologically identified apoptotic cells. ApopTag uses the terminal deoxytidyl transferase (TdT)-mediated dUTP nick-end labeling assay (TUNEL assay) to specifically stain single- and double-stranded DNA breaks associated with apoptosis. Cells were stained according to the instructions of the manufacturer. The percentage of the fluorescein-positive cells was calculated over a 4-hour period in several separate experiments. The Texas Red remained visible after fixation and again was used to identify microinjected cells.
Cytosolic Calcium [Ca2+]i Analysis
Cells grown on glass coverslips mounted over holes in 60-mm dishes were incubated with 5 µmol/L Fura 2/AM (Molecular Probes, Eugene, OR) for 90 minutes at 22°C after microinjection of cytochrome c. Analysis was performed by digital imaging fluorescence microscopy (DIFM), using a Nikon inverted microscope and a dual-excitation chopper-based Tracor Northern FluoroPlex III and image analysis system (Tracor Northern, Madison, WI) as previously described.12 After loading, three to five fields of Fura-2-loaded uninjected control cells were selected, and image pairs were collected at 340/380-nm excitation. Two hours after microinjection of cytochrome c and Fura-2/AM loading, image pairs were collected at 20-minute intervals for up to 6 hours in fields having apoptotic cells. [Ca2+]i calibrations were performed as described previously.12 The ratioed image pairs were displayed using a pseudocolor or gray scale to indicate levels of [Ca2+]i.
Mitochondrial Membrane Potential Analysis
The mitochondrial membrane potential (MMP) (terminology defining the integrity of the inner mitochondrial membrane and associated respiratory chain complexes) was measured indirectly by use of the vital fluorochrome dye rhodamine 123. Loss of membrane integrity is indicated when the dye leaves the mitochondria. The time of opening of the mitochondria permeability pore(s) (high-conductance pore(s)), which precipitates the mitochondrial permeability transition, is also often indirectly established by the loss of rhodamine 123 from mitochondria. Cytochrome c-microinjected cells were incubated with 5 µg/ml rhodamine 123 (Sigma) for 2040 minutes at 37°C. Mitochondrial staining in apoptotic cells was monitored and photographed for 4 hours by both fluorescence and phase microscopy with the inverted Olympus microscope. Bright fluorescence was maintained by reincubating the grids periodically in medium with rhodamine 123.
Electron Microscopy
For transmission electron microscopy (TEM), cells were plated onto grid slides precoated with a thin carbon film, microinjected with cytochrome c, and then fixed after 0.5, 1, 1.5, 2, and 4 hours with 2% glutaraldehyde in 0.1 mol/L sodium cacodylate buffer (pH 7.3) for 216 hours, followed by 1% osmium tetroxide fixation (1 hour at 22°C). Before fixation, apoptotic cells were located on grid slide windows and accurately mapped on a clear acetate sheet for future reference and for final epoxy block trimming. Cells on grid slides were gently dehydrated and infiltrated with Polybed 812 epoxy resin (Polysciences), mounted on a blank epoxy block, and cured. Blocks were trimmed using the prefixation acetate maps to pinpoint exact cell location, and thin sections were cut, stained, examined, and photographed with a JEOL EX1200 transmission electron microscope. For scanning electron microscopy (SEM) samples were fixed, dehydrated, critical-point dried, gold coated, examined, and photographed with an AMR-1000 scanning electron microscope.
Treatment of Cells with Protease and Enzyme Inhibitors
Cells were incubated with either the caspase-3 inhibitor Ac-DEVD-CHO (Ac-Asp-Glu-Val-L-aspartic acid aldehyde) or the caspase 1-inhibitor YVAF-CHO (Ac-Tyr-Val-Ala-ASp aldehyde) (Bioscience, King of Prussia, PA) for 1.5 hours before microinjection of cytochrome c. Both inhibitors were used at various concentrations ranging from 5 to 200 µmol/L and were kept in the media throughout the course of the experiment.
Microinjection of Bcl-2
Cytochrome c was microinjected into NRK-52E cells that had been stably transfected with the Bcl-2 gene (NRK-Bcl-2) and which overproduced Bcl-2 protein.13 In separate experiments, the vector pD5-neo/Bcl-2 was microinjected into the nuclei of NRK-52E cells 24 hours before the coinjection of cytochrome c and Texas Red dextran. The vector was kindly supplied by Dr. Paul Amstad.14
Actin Staining
Injected cells on grid slides were sampled at 30-minute intervals up to 4 hours, fixed in 1.5% formaldehyde (1030 minutes), and then stored in PBS. Cells were first permeabilized with Triton X-100 (0.5%) for 3 minutes before staining for 30 minutes with a 1:10 dilution of fluorescein phalloidin (Molecular Probes). Grids were then mounted on coverslips with Vectashield medium and photographed by fluorescence microscopy, using either a fluorescein filter or a dual Texas Red/fluorescein filter.
ATP Depletion
Cells grown on grids were preincubated in DMEM without serum for 30 minutes and then treated with freshly prepared potassium cyanide to inhibit mitochondrial respiration and sodium iodoacetate to block glycolysis (KCN + IAA), in equal concentrations ranging from 0.25 to 1 mmol/L for different times (0.5, 1, 1.5, 24 hours) before microinjection with cytochrome c. The percentage of dead cells was calculated for each time point, and a final optimum concentration of 0.25 mmol/L was selected. Cells were also grown in flasks for adenosine triphosphate (ATP) evaluation and treated with 0.25 mmol/L KCN and 0.25 mmol/L IAA for time periods similar to those mentioned above but were not microinjected with cytochrome c. At zero time and at each time point, a flask of cells was exposed to 1 ml trypsin-EDTA for 10 minutes, followed by the addition of 2 ml DMEM without serum. Aliquots of cells were analyzed by a luciferase method,15 using the Sigma Assay Kit and a luminometer (model TD-20-20; Turner Designs). ATP concentrations were expressed in fmol/cell.
| Results |
|---|
|
|
|---|
Control Cells
The untreated NRK-52E cells in culture formed colonies of
epithelial cells that were polyhedral in shape and contained eccentric
nuclei that bulged upward and had multiple nucleoli. At 100%
confluency, the cells exhibited a compact cobblestone appearance, as
reported previously.10,11
The surfaces of the cells were
covered with short microvilli (Figure 1A)
, and the apical region contained
vesicles, tubules, and vacuoles similar to those of PTE in
vivo. The mitochondria were elongated and had a moderately dense
matrix (Figure 2A)
. A network of actin
was situated immediately below the apical cell surface, and a
well-developed network of actin bundles was seen in the cytosol with
phalloidin staining. In apical regions of the cells, microtubules were
associated with the actin filaments and were seen elsewhere in the
cytoplasm, where they formed a characteristic network. The Golgi
apparatus was well developed and surrounded by multivesicular bodies,
secondary lysosomes, and occasional triglyceride droplets.
|
|
Within 30 minutes after microinjection of cytochrome c,
some cells began to exhibit apoptotic changes, but others changed less
rapidly. Within 23 hours approximately 6070% of the microinjected
cells became apoptotic, as evaluated by morphological criteria (Figure 3)
. In the experiments where cells were
stained with ApopTag, about 7080% of the microinjected cells became
fluorescent (or ApopTag-positive) within 23 hours (Figure 4)
. Initially, the cells exhibited a very
rapid shrinkage phase, becoming roundish and leaving behind cytoplasmic
strands (Figures 1B and 5B)
. The active
phase immediately followed this. In this phase the cells exhibited
rapid extension and retraction of buds or pseudopods (not to be
confused with bleb formations seen in oncosis) over the entire cell
surface (Figures 1B, 1C, 5C, 6E, 7A, and 7B)
. Many of these pseudopods had
secondary pseudopods (Figure 1B
, arrows) that also extended and
retracted. This active phase lasted for a period of approximately 30
minutes to 4 hours, although occasionally a few cells remained active
for as long as 6 hours. In the early active phase there is positive
cell staining after use of the TUNEL ApopTag kit (Figure 8, A and B)
.
|
|
|
|
|
|
|
|
|
Spherical Phase
Beginning approximately 24 hours after microinjection, the cells
became spherical and quiescent (Figures 1D, 2D, 7C, 8C, 8D, and 9B, d
f). SEM confirmed the spherical shape and showed some remnants of
the retraction processes (Figure 1D)
. The surface of these cells did
not show pseudopods, but instead often revealed a pitted appearance
(Figure 1D
, arrows) corresponding to the vacuoles seen by TEM.
Spherical cells showed positive staining after the use of the TUNEL
ApopTag assay kit, indicating DNA fragmentation (Figure 8
C,D). TEM
typically showed a polarized appearance with the eccentric nucleus at
one pole and a series of variably sized membrane-bound vacuoles at the
other pole (Figure 2D)
. Many of these apical vacuoles were highly
dilated, and some could be seen to communicate with the cell surface.
The cytosol was relatively electron-dense, with closely packed
ribosomes (Figure 11)
. The cytosol also
contained numerous phagolysosomes (Figure 11
, arrowheads) and
frequently contained bundles of filaments similar to those seen in the
active phase. At this stage the nuclei showed intense chromatin
clumping (Figure 12)
and marked shape
changes, sometimes resulting in multiple nuclear profiles in any one
thin-section plane. In most cases the nuclear processes, which were
often quite small, could be identified by the recognition of a nuclear
envelope and the fact that many distant nuclear protrusions could be
seen to connect with the main part of the nucleus (Figure 12
, inset).
However, nuclear chromatin could sometimes be seen in the pseudopods of
active-phase cells without any identifiable nuclear envelope (Figure 2, B and C
, arrows). Most nuclei were markedly irregular and frequently
contained nuclear inclusions composed of aggregates of filaments
(Figure 2D
, inset). Nucleoli often showed marked segregation. The RER,
on the other hand, was even more dilated than in the active phase
(Figures 11 and 12)
. In general, the mitochondria were seen as rounded
profiles that showed high-amplitude swelling of the inner compartments
(Figure 11
, arrows). The MMP, however, remained unchanged in virtually
all of the cells observed (Figure 6F)
. At the late stages of the
spherical phase, but before cell death,
[Ca2+]i was markedly
increased (Figure 9B, d
f).
|
Fragments of cells in the necrotic phase were seen adjacent to
cells in the active and spherical phases (Figure 2B
, lower left,
arrowhead). In these cells, the cytosol was swollen, as was the RER and
the mitochondria, which often showed flocculent intramatrical
densities. These changes were identical to those seen after many other
injuries that do not cause apoptosis, such as ischemia or mercuric
chloride toxicity.
Cytosolic Calcium Analysis
DIFM studies showed that normal cells had a
[Ca2+]i range of 50100
nmol/L, and cells in the active phase showed a slight increase to about
200 nmol/L (Figure 9B, a
c). There was an increase to approximately
900 nmol/L in the late stages of the spherical phase, just before cell
death (Figure 9B, d
f).
Caspase-3 Inhibition
Pretreatment of cells with Ac-DEVD-CHO before and after
microinjection of cytochrome c prevented all of the changes
of the active phase, whereas pretreatment with YVAD-CHO apparently had
no effect (Figure 3)
.
Excess Bcl-2
Microinjection of cells with cytochrome c after
overexpression of Bcl-2, resulting from either transfection
by NRK-Bcl-2 or microinjection with the
pD5-neo/Bcl-2 vector, resulted in no inhibition of the
apoptotic pathway (Figure 3)
.
ATP Analysis
Preincubation of cells with 0.25 mmol/L KCN + 0.25 mmol/L
IAA for 1.5 hours before cytochrome c microinjection showed
a maximum of about 30% apoptosis in microinjected cells by 4 hours.
However, preincubation for 2 hours or longer with 0.25 mM KCN + 0.25 mM
IAA followed by microinjection of cytochrome c resulted in
the complete absence of apoptosis (Figure 13)
. (Note: Control cells in DMEM
without serum, microinjected with cytochrome c, resulted in
almost 100% of the cells becoming apoptotic by 12 hours, whereas
microinjected cells in DMEM with serum had a maximum of about 6070%
apoptosis by 23 hours (Figure 3)
.)
|
| Discussion |
|---|
|
|
|---|
These studies clearly show that microinjection of cytochrome c in NRK-52E cells resulted in apoptosis, followed by cell death and necrosis. The changes proceeded rapidly and were particularly dramatic when viewed by time-lapse video microscopy. The apoptotic phase began as early as 30 minutes after microinjection, and within 23 hours 6070% of the microinjected cells (as evaluated morphologically) and 7080% by the ApopTag assay were apoptotic. Cell death, as indicated by nuclear propidium iodide staining, occurred at the late spherical phase, frequently when the cells were detaching from the substrate.
Examination of time-lapse video tapes (accelerated 60 times) revealed that the process of cytochrome c-induced apoptosis was extremely dynamic. (The excellent review on cell death by G. Majno and I. Joris2 provides earlier descriptions of this phenomenon.) In our most graphic video sequences, the changes occurred explosively once they began. The initial shrinkage phase of the cell was followed by active pseudopod formation around the periphery of the cell. Although this active phase typically lasted for 11.5 hours, some cells continued active pseudopod formation for as long as 6 hours. This prolonged active and prelethal phase of apoptosis strongly suggests that ATP is required for this violent activity, as has been suggested by other models. Reports by Tsujimoto16 and Lieberthal et al17 support the hypothesis that both cytochrome c and a sizable pool of ATP are necessary to induce apoptosis. Our preliminary experiments using KCN + IAA as a model of inhibition of energy metabolism showed that cells treated with 0.25 mmol/L concentrations of both for 2 hours before microinjection with cytochrome c resulted in a reduction of ATP and complete prevention of apoptosis. The ATP assay data showed a correlation between the loss of ATP and the absence of apoptosis, which also supports the hypothesis that apoptosis is an ATP-requiring phenomenon. The maintenance of ATP in the active phase provides an explanation for the relatively normal-appearing mitochondria and normal range of cytosolic calcium seen in this phase. After the active phase, the cells again became quiescent. They changed shape, rounded up, and became more or less spherical. The cells remained in this conformation until they began to die (as shown by uptake of PI into nuclei) and detach from the coverslip.
Morphological Alterations
Shape Changes
The initial shrinkage and retraction of the cells in the first phase as observed by phase-contrast microscopy is most likely related to loss of water from the cytosol. Bortner and co-workers18 have hypothesized that shrinkage is secondary to loss of K+ and Na+ from the cytosol in that K+ at normal concentrations (when efflux is prevented) inhibited DNA fragmentation and caspase-3 activity, suggesting an important early role for K+ loss in apoptosis.
The subsequent active phase of pseudopod formation and the ultimate rounding up and retraction of the cells imply marked dynamic alterations in the cytoskeleton, probably involving actin and associated proteins. During this phase, actin staining patterns were markedly abnormal, with loss of the normal F-actin patterns and replacement by patchy, homogeneously staining areas throughout the cell. Actin staining appeared to be concentrated at the base of the pseudopods, whereas the pseudopods per se showed almost no staining. Similar bands of actin staining were also observed at the base of cytoplasmic blebs in rat PTE cells after treatment with HgCl2.19
The fact that caspase-3 inhibition eliminates all of these shape changes and changes in actin staining leads us to presume that caspase-3 is directly involved. Actin is known to be a major cellular substrate for caspase-3, and Williamss group20 has reported that caspase-3 cuts gelsolin, which is a Ca2+-dependent actin-severing and -capping protein. The cleaved gelsolin fragments can, in turn, sever actin polymers. Microinjection of cells with NH2-terminal gelsolin fragments was shown to result in actin depolymerization and cellular shape changes, whereas gelsolin-null cells were shown to be resistant to the apoptotic shape changes induced by tumor necrosis factor (TNF) plus cycloheximide.20 Because our data showed no significant [Ca2+]i elevation during the active phase, we presume that normal concentrations of [Ca2+]i are sufficient for these putative gelsolin-induced changes.
Mitochondrial Changes
The mitochondria also underwent dynamic changes in conformation, which related to the phases of apoptosis. In the untreated NRK cells, the mitochondria appeared as long, thread-like bodies that were in continual movement, as seen in time-lapse video microscopy. By TEM, they appeared as elongated profiles with moderately dense matrices and narrow intercristal spaces. During the active phase, where there is dramatic extension and retraction of pseudopods, mitochondria remained in their orthodox conformation. Some, however, show matrical condensation. The latter can be seen during periods of rapid ATP utilization, such as state 3 respiration,21 and is completely compatible with the presumed ATP requirement for cells in the active phase, as mentioned above.
When the cells entered the quiescent spherical phase, the mitochondria began to show varying degrees of matrical swelling, similar to that which occurs in oncosis in renal tubules after other types of prelethal injury, such as total ischemia in vivo,22 or after exposure to many nephrotoxins, including mercuric chloride.12 This swelling is known to be reversible and is usually associated with ATP depletion.3 In the spherical phase the MMP initially remains intact, as measured by rhodamine 123 retention, demonstrating that the mitochondrial permeability transition had not occurred. The progression to cell death followed by necrosis then takes place and the mitochondria show flocculent densities. The identical changes leading up to cell death and necrosis are shared by apoptosis and oncosis, as recently pointed out by LeMasters.23
Because treatment with Ac-DEVD-CHO prevented all of the mitochondrial changes, it is presumed that caspase-3 is either directly or indirectly involved. On the other hand, overexpression of Bcl-2 did not prevent these mitochondrial changes, which implies that, at least in this system, Bcl-2 overexpression did not prevent changes in mitochondrial inner membrane permeability. Furthermore, the observation that Bcl-2 overexpression did not protect against apoptosis may render it less likely that caspase-3 produces mitochondrial swelling by attacking the mitochondrial permeability transition pore complex directly.24 In our experiments, Bcl-2 protection was not observed downstream of cytochrome c, as suggested by Rosse et al.25 However, they used Bax-induced apoptosis, which they reported invokes a different type of cell death pathway.25 At the same time it has been reported that Bcl-2 can be cleaved, at least in some circumstances, by caspases. Furthermore, cleavage of Bcl-2 may not only inactivate these proteins, but may also produce fragments that promote apoptosis.26
The results of previous work in our laboratory have indicated that Bcl-2 protection resulting from oxidant injury is due to mitochondrial buffering of increased [Ca2+]i.13 This buffering has also been reported to occur in neural cells.27 Another possibility for this protection is that the change in inner membrane permeability may be secondary to caspase-induced activation of a phospholipase A2, as suggested by Atsumi et al28 and Wissing et al.29
This study has shown that microinjection of cytochrome c into NRK-52E cells results in rapid apoptosis that can be separated into four distinct morphological phases: shrinkage, active, spherical, and necrotic. It was also found that the caspase-3 inhibitor Ac-DEVD-CHO totally prevented apoptosis, whereas excess Bcl-2 did not. In addition, preliminary data showed that ATP is a requirement for the active phase of apoptosis.
| Acknowledgements |
|---|
| Footnotes |
|---|
Accepted for publication October 13, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Maruyama, G. Takemura, N. Tohse, T. Ohkusa, Y. Ikeda, K. Tsuchiya, S. Minatoguchi, M. Matsuzaki, T. Fujiwara, and H. Fujiwara Synchronous progression of calcium transient-dependent beating and sarcomere destruction in apoptotic adult cardiomyocytes Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1493 - H1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Potts, A. E. Vaughn, H. McDonough, C. Patterson, and M. Deshmukh Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP J. Cell Biol., December 19, 2005; 171(6): 925 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Wright, M. W. Linhoff, P. R. Potts, and M. Deshmukh Decreased apoptosome activity with neuronal differentiation sets the threshold for strict IAP regulation of apoptosis J. Cell Biol., October 25, 2004; 167(2): 303 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Potts, S. Singh, M. Knezek, C. B. Thompson, and M. Deshmukh Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis J. Cell Biol., November 24, 2003; 163(4): 789 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Anestal and E. S. J. Arner Rapid Induction of Cell Death by Selenium-compromised Thioredoxin Reductase 1 but Not by the Fully Active Enzyme Containing Selenocysteine J. Biol. Chem., April 25, 2003; 278(18): 15966 - 15972. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deshmukh, C. Du, X. Wang, and E. M. Johnson Jr Exogenous Smac Induces Competence and Permits Caspase Activation in Sympathetic Neurons J. Neurosci., September 15, 2002; 22(18): 8018 - 8027. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Roberg, K. Kagedal, and K. Ollinger Microinjection of Cathepsin D Induces Caspase-Dependent Apoptosis in Fibroblasts Am. J. Pathol., July 1, 2002; 161(1): 89 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Peherstorfer, B. Mayer, S. Boehm, A. Lukas, P. Hauser, G. Mayer, and R. Oberbauer Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells Am J Physiol Renal Physiol, July 1, 2002; 283(1): F190 - F196. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maruyama, G. Takemura, T. Aoyama, K. Hayakawa, M. Koda, Y. Kawase, X. Qiu, Y. Ohno, S. Minatoguchi, K. Miyata, et al. Dynamic Process of Apoptosis in Adult Rat Cardiomyocytes Analyzed Using 48-Hour Videomicroscopy and Electron Microscopy : Beating and Rate are Associated with the Apoptotic Process Am. J. Pathol., August 1, 2001; 159(2): 683 - 691. [Abstract] [Full Text] |
||||
![]() |
Y. Okada, E. Maeno, T. Shimizu, K. Dezaki, J. Wang, and S. Morishima Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD) J. Physiol., April 1, 2001; 532(1): 3 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zieler and J. A. Dvorak Invasion in vitro of mosquito midgut cells by the malaria parasite proceeds by a conserved mechanism and results in death of the invaded midgut cells PNAS, October 10, 2000; 97(21): 11516 - 11521. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Yu and D. W. Choi Ions, cell volume, and apoptosis PNAS, August 15, 2000; 97(17): 9360 - 9362. [Full Text] [PDF] |
||||
![]() |
L. Michea, C. Combs, P. Andrews, N. Dmitrieva, and M. B. Burg Mitochondrial dysfunction is an early event in high-NaCl-induced apoptosis of mIMCD3 cells Am J Physiol Renal Physiol, June 1, 2002; 282(6): F981 - F990. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |